A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study)
Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter ana...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Meattini, Icro [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells - Han, Xiaobing ELSEVIER, 2021, journal of the European Society for Therapeutic Radiology and Oncology, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:131 ; year:2019 ; pages:208-214 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.radonc.2018.07.015 |
|---|
| Katalog-ID: |
ELV045820996 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV045820996 | ||
| 003 | DE-627 | ||
| 005 | 20230624120408.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191021s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.radonc.2018.07.015 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000523.pica |
| 035 | |a (DE-627)ELV045820996 | ||
| 035 | |a (ELSEVIER)S0167-8140(18)33414-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |a 540 |q VZ |
| 100 | 1 | |a Meattini, Icro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) |
| 264 | 1 | |c 2019 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT. | ||
| 650 | 7 | |a Ductal carcinoma in situ |2 Elsevier | |
| 650 | 7 | |a Multicenter study |2 Elsevier | |
| 650 | 7 | |a Breast cancer |2 Elsevier | |
| 650 | 7 | |a Radiotherapy |2 Elsevier | |
| 650 | 7 | |a Prognostic factors |2 Elsevier | |
| 700 | 1 | |a Pasinetti, Nadia |4 oth | |
| 700 | 1 | |a Meduri, Bruno |4 oth | |
| 700 | 1 | |a De Rose, Fiorenza |4 oth | |
| 700 | 1 | |a De Santis, Maria Carmen |4 oth | |
| 700 | 1 | |a Franco, Pierfrancesco |4 oth | |
| 700 | 1 | |a Lancellotta, Valentina |4 oth | |
| 700 | 1 | |a Rossi, Francesca |4 oth | |
| 700 | 1 | |a Saieva, Calogero |4 oth | |
| 700 | 1 | |a Desideri, Isacco |4 oth | |
| 700 | 1 | |a Delli Paoli, Camilla |4 oth | |
| 700 | 1 | |a D'Angelo, Elisa |4 oth | |
| 700 | 1 | |a Triggiani, Luca |4 oth | |
| 700 | 1 | |a Bastiani, Paolo |4 oth | |
| 700 | 1 | |a Alongi, Filippo |4 oth | |
| 700 | 1 | |a Lozza, Laura |4 oth | |
| 700 | 1 | |a Aristei, Cynthia |4 oth | |
| 700 | 1 | |a Ricardi, Umberto |4 oth | |
| 700 | 1 | |a Scorsetti, Marta |4 oth | |
| 700 | 1 | |a Livi, Lorenzo |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Han, Xiaobing ELSEVIER |t Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |d 2021 |d journal of the European Society for Therapeutic Radiology and Oncology |g Amsterdam [u.a.] |w (DE-627)ELV00004122X |
| 773 | 1 | 8 | |g volume:131 |g year:2019 |g pages:208-214 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.radonc.2018.07.015 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 131 |j 2019 |h 208-214 |g 7 | ||
| author_variant |
i m im |
|---|---|
| matchkey_str |
meattiniicropasinettinadiameduribrunoder:2019----:ntoamlietrtdo17diptettetdihratosrigugradhl |
| hierarchy_sort_str |
2019 |
| publishDate |
2019 |
| allfields |
10.1016/j.radonc.2018.07.015 doi GBV00000000000523.pica (DE-627)ELV045820996 (ELSEVIER)S0167-8140(18)33414-5 DE-627 ger DE-627 rakwb eng 570 540 VZ Meattini, Icro verfasserin aut A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 2019 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT. Ductal carcinoma in situ Elsevier Multicenter study Elsevier Breast cancer Elsevier Radiotherapy Elsevier Prognostic factors Elsevier Pasinetti, Nadia oth Meduri, Bruno oth De Rose, Fiorenza oth De Santis, Maria Carmen oth Franco, Pierfrancesco oth Lancellotta, Valentina oth Rossi, Francesca oth Saieva, Calogero oth Desideri, Isacco oth Delli Paoli, Camilla oth D'Angelo, Elisa oth Triggiani, Luca oth Bastiani, Paolo oth Alongi, Filippo oth Lozza, Laura oth Aristei, Cynthia oth Ricardi, Umberto oth Scorsetti, Marta oth Livi, Lorenzo oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:131 year:2019 pages:208-214 extent:7 https://doi.org/10.1016/j.radonc.2018.07.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 131 2019 208-214 7 |
| spelling |
10.1016/j.radonc.2018.07.015 doi GBV00000000000523.pica (DE-627)ELV045820996 (ELSEVIER)S0167-8140(18)33414-5 DE-627 ger DE-627 rakwb eng 570 540 VZ Meattini, Icro verfasserin aut A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 2019 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT. Ductal carcinoma in situ Elsevier Multicenter study Elsevier Breast cancer Elsevier Radiotherapy Elsevier Prognostic factors Elsevier Pasinetti, Nadia oth Meduri, Bruno oth De Rose, Fiorenza oth De Santis, Maria Carmen oth Franco, Pierfrancesco oth Lancellotta, Valentina oth Rossi, Francesca oth Saieva, Calogero oth Desideri, Isacco oth Delli Paoli, Camilla oth D'Angelo, Elisa oth Triggiani, Luca oth Bastiani, Paolo oth Alongi, Filippo oth Lozza, Laura oth Aristei, Cynthia oth Ricardi, Umberto oth Scorsetti, Marta oth Livi, Lorenzo oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:131 year:2019 pages:208-214 extent:7 https://doi.org/10.1016/j.radonc.2018.07.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 131 2019 208-214 7 |
| allfields_unstemmed |
10.1016/j.radonc.2018.07.015 doi GBV00000000000523.pica (DE-627)ELV045820996 (ELSEVIER)S0167-8140(18)33414-5 DE-627 ger DE-627 rakwb eng 570 540 VZ Meattini, Icro verfasserin aut A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 2019 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT. Ductal carcinoma in situ Elsevier Multicenter study Elsevier Breast cancer Elsevier Radiotherapy Elsevier Prognostic factors Elsevier Pasinetti, Nadia oth Meduri, Bruno oth De Rose, Fiorenza oth De Santis, Maria Carmen oth Franco, Pierfrancesco oth Lancellotta, Valentina oth Rossi, Francesca oth Saieva, Calogero oth Desideri, Isacco oth Delli Paoli, Camilla oth D'Angelo, Elisa oth Triggiani, Luca oth Bastiani, Paolo oth Alongi, Filippo oth Lozza, Laura oth Aristei, Cynthia oth Ricardi, Umberto oth Scorsetti, Marta oth Livi, Lorenzo oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:131 year:2019 pages:208-214 extent:7 https://doi.org/10.1016/j.radonc.2018.07.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 131 2019 208-214 7 |
| allfieldsGer |
10.1016/j.radonc.2018.07.015 doi GBV00000000000523.pica (DE-627)ELV045820996 (ELSEVIER)S0167-8140(18)33414-5 DE-627 ger DE-627 rakwb eng 570 540 VZ Meattini, Icro verfasserin aut A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 2019 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT. Ductal carcinoma in situ Elsevier Multicenter study Elsevier Breast cancer Elsevier Radiotherapy Elsevier Prognostic factors Elsevier Pasinetti, Nadia oth Meduri, Bruno oth De Rose, Fiorenza oth De Santis, Maria Carmen oth Franco, Pierfrancesco oth Lancellotta, Valentina oth Rossi, Francesca oth Saieva, Calogero oth Desideri, Isacco oth Delli Paoli, Camilla oth D'Angelo, Elisa oth Triggiani, Luca oth Bastiani, Paolo oth Alongi, Filippo oth Lozza, Laura oth Aristei, Cynthia oth Ricardi, Umberto oth Scorsetti, Marta oth Livi, Lorenzo oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:131 year:2019 pages:208-214 extent:7 https://doi.org/10.1016/j.radonc.2018.07.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 131 2019 208-214 7 |
| allfieldsSound |
10.1016/j.radonc.2018.07.015 doi GBV00000000000523.pica (DE-627)ELV045820996 (ELSEVIER)S0167-8140(18)33414-5 DE-627 ger DE-627 rakwb eng 570 540 VZ Meattini, Icro verfasserin aut A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 2019 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT. Ductal carcinoma in situ Elsevier Multicenter study Elsevier Breast cancer Elsevier Radiotherapy Elsevier Prognostic factors Elsevier Pasinetti, Nadia oth Meduri, Bruno oth De Rose, Fiorenza oth De Santis, Maria Carmen oth Franco, Pierfrancesco oth Lancellotta, Valentina oth Rossi, Francesca oth Saieva, Calogero oth Desideri, Isacco oth Delli Paoli, Camilla oth D'Angelo, Elisa oth Triggiani, Luca oth Bastiani, Paolo oth Alongi, Filippo oth Lozza, Laura oth Aristei, Cynthia oth Ricardi, Umberto oth Scorsetti, Marta oth Livi, Lorenzo oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:131 year:2019 pages:208-214 extent:7 https://doi.org/10.1016/j.radonc.2018.07.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 131 2019 208-214 7 |
| language |
English |
| source |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:131 year:2019 pages:208-214 extent:7 |
| sourceStr |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:131 year:2019 pages:208-214 extent:7 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Ductal carcinoma in situ Multicenter study Breast cancer Radiotherapy Prognostic factors |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| authorswithroles_txt_mv |
Meattini, Icro @@aut@@ Pasinetti, Nadia @@oth@@ Meduri, Bruno @@oth@@ De Rose, Fiorenza @@oth@@ De Santis, Maria Carmen @@oth@@ Franco, Pierfrancesco @@oth@@ Lancellotta, Valentina @@oth@@ Rossi, Francesca @@oth@@ Saieva, Calogero @@oth@@ Desideri, Isacco @@oth@@ Delli Paoli, Camilla @@oth@@ D'Angelo, Elisa @@oth@@ Triggiani, Luca @@oth@@ Bastiani, Paolo @@oth@@ Alongi, Filippo @@oth@@ Lozza, Laura @@oth@@ Aristei, Cynthia @@oth@@ Ricardi, Umberto @@oth@@ Scorsetti, Marta @@oth@@ Livi, Lorenzo @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV00004122X |
| dewey-sort |
3570 |
| id |
ELV045820996 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045820996</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624120408.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2018.07.015</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000523.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045820996</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(18)33414-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Meattini, Icro</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ductal carcinoma in situ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Multicenter study</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Radiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prognostic factors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pasinetti, Nadia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meduri, Bruno</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Rose, Fiorenza</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Santis, Maria Carmen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Franco, Pierfrancesco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lancellotta, Valentina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rossi, Francesca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saieva, Calogero</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Desideri, Isacco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Delli Paoli, Camilla</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">D'Angelo, Elisa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Triggiani, Luca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bastiani, Paolo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alongi, Filippo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lozza, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aristei, Cynthia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ricardi, Umberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Scorsetti, Marta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Livi, Lorenzo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:131</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:208-214</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2018.07.015</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">131</subfield><subfield code="j">2019</subfield><subfield code="h">208-214</subfield><subfield code="g">7</subfield></datafield></record></collection>
|
| author |
Meattini, Icro |
| spellingShingle |
Meattini, Icro ddc 570 Elsevier Ductal carcinoma in situ Elsevier Multicenter study Elsevier Breast cancer Elsevier Radiotherapy Elsevier Prognostic factors A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) |
| authorStr |
Meattini, Icro |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00004122X |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 540 VZ A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) Ductal carcinoma in situ Elsevier Multicenter study Elsevier Breast cancer Elsevier Radiotherapy Elsevier Prognostic factors Elsevier |
| topic |
ddc 570 Elsevier Ductal carcinoma in situ Elsevier Multicenter study Elsevier Breast cancer Elsevier Radiotherapy Elsevier Prognostic factors |
| topic_unstemmed |
ddc 570 Elsevier Ductal carcinoma in situ Elsevier Multicenter study Elsevier Breast cancer Elsevier Radiotherapy Elsevier Prognostic factors |
| topic_browse |
ddc 570 Elsevier Ductal carcinoma in situ Elsevier Multicenter study Elsevier Breast cancer Elsevier Radiotherapy Elsevier Prognostic factors |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
n p np b m bm r f d rf rfd s m c d smc smcd p f pf v l vl f r fr c s cs i d id p c d pc pcd e d ed l t lt p b pb f a fa l l ll c a ca u r ur m s ms l l ll |
| hierarchy_parent_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| hierarchy_parent_id |
ELV00004122X |
| dewey-tens |
570 - Life sciences; biology 540 - Chemistry |
| hierarchy_top_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV00004122X |
| title |
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) |
| ctrlnum |
(DE-627)ELV045820996 (ELSEVIER)S0167-8140(18)33414-5 |
| title_full |
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) |
| author_sort |
Meattini, Icro |
| journal |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| journalStr |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
208 |
| author_browse |
Meattini, Icro |
| container_volume |
131 |
| physical |
7 |
| class |
570 540 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Meattini, Icro |
| doi_str_mv |
10.1016/j.radonc.2018.07.015 |
| dewey-full |
570 540 |
| title_sort |
a national multicenter study on 1072 dcis patients treated with breast-conserving surgery and whole breast radiotherapy (cobcg-01 study) |
| title_auth |
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) |
| abstract |
Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT. |
| abstractGer |
Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT. |
| abstract_unstemmed |
Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) |
| url |
https://doi.org/10.1016/j.radonc.2018.07.015 |
| remote_bool |
true |
| author2 |
Pasinetti, Nadia Meduri, Bruno De Rose, Fiorenza De Santis, Maria Carmen Franco, Pierfrancesco Lancellotta, Valentina Rossi, Francesca Saieva, Calogero Desideri, Isacco Delli Paoli, Camilla D'Angelo, Elisa Triggiani, Luca Bastiani, Paolo Alongi, Filippo Lozza, Laura Aristei, Cynthia Ricardi, Umberto Scorsetti, Marta Livi, Lorenzo |
| author2Str |
Pasinetti, Nadia Meduri, Bruno De Rose, Fiorenza De Santis, Maria Carmen Franco, Pierfrancesco Lancellotta, Valentina Rossi, Francesca Saieva, Calogero Desideri, Isacco Delli Paoli, Camilla D'Angelo, Elisa Triggiani, Luca Bastiani, Paolo Alongi, Filippo Lozza, Laura Aristei, Cynthia Ricardi, Umberto Scorsetti, Marta Livi, Lorenzo |
| ppnlink |
ELV00004122X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.radonc.2018.07.015 |
| up_date |
2024-07-06T18:34:42.617Z |
| _version_ |
1803855732532051968 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045820996</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624120408.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2018.07.015</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000523.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045820996</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(18)33414-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Meattini, Icro</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ductal carcinoma in situ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Multicenter study</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Radiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prognostic factors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pasinetti, Nadia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meduri, Bruno</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Rose, Fiorenza</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Santis, Maria Carmen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Franco, Pierfrancesco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lancellotta, Valentina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rossi, Francesca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saieva, Calogero</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Desideri, Isacco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Delli Paoli, Camilla</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">D'Angelo, Elisa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Triggiani, Luca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bastiani, Paolo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alongi, Filippo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lozza, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aristei, Cynthia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ricardi, Umberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Scorsetti, Marta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Livi, Lorenzo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:131</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:208-214</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2018.07.015</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">131</subfield><subfield code="j">2019</subfield><subfield code="h">208-214</subfield><subfield code="g">7</subfield></datafield></record></collection>
|
| score |
7.4021063 |